Medication‑assisted treatment is an evidence‑based intervention that combines FDA‑approved medications with counseling and behavioral therapy. For alcohol use disorder, the FDA has approved three primary medications:
- Naltrexone (oral or extended‑release injectable): reduces cravings and blocks the reinforcing effects of alcohol
- Acamprosate: stabilizes glutamate signaling to reduce post‑acute withdrawal symptoms
- Disulfiram: creates an aversive reaction if alcohol is consumed (appropriate only for select, motivated patients)
These medications are recommended by NIAAA, ASAM, and the American Psychiatric Association as part of comprehensive AUD treatment.
Our physicians evaluate liver function, psychiatric history, withdrawal severity, and relapse patterns before prescribing MAT, and medications are always combined with psychotherapy and relapse‑prevention planning.